59O - Alternative methods of PET-CT interpretation: can we improve mediastinal nodal staging in lung cancer patients?

Date 28 March 2014
Event ELCC 2014
Session Proffered papers 3 - Screening, staging and epidemiology
Topics Imaging, Diagnosis and Staging
Lung and other Thoracic Tumours
Presenter Matthew Evison
Citation Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131
Authors M. Evison1, P. Crosbie2, J. Martin1, P. Barber1, R. Booton2
  • 1North West Lung Centre, University Hospital South Manchester, M23 9LT - Manchester/UK
  • 2University Of Manchester, Institute of Inflammation and Repair, M13 9PL - Manchester/UK



In the absence of distant metastases, lymph node staging becomes the pivotal factor in determining treatment and prognosis for lung cancer patients. The sensitivity of PET-CT for nodal staging remains sub-optimal. Using a different SUV ‘cut-off’ value to define a positive lymph node (traditionally 2.5) or using the ratio of the lymph node SUV compared to the primary tumour SUV may provide more clinically relevant information.